Chronic HBV and HDV infections are worldwide problem, causing severe liver injury with a major risk of liver cancer. A number of host proteins have been identified as putative receptors for HBV and HDV binding to target cells, but these receptors fail to support subsequent viral entry and the initiation of viral genome replication when expressed in liver cell lines that are not susceptible to HBV or HDV infection. To elucidate the molecular details mediating viral attachment and entry, the following specific aims are proposed: (1) Various natural and mutated forms of HBV envelope proteins will be used to determine optimal conditions for the controlled assembly of HDV particles that contain the HDV RNA genome; (2) These particles will then be used to test hypotheses regarding the requirements of proteolytic cleavage for virus attachment, entry and the initiation of genome replication. The results from this proposed research could lead to the development of antiviral strategies and of therapeutic treatment for chronic hepatitis patients. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AI056817-01A1
Application #
6787001
Study Section
Special Emphasis Panel (ZRG1-F08 (20))
Program Officer
Berard, Diana S
Project Start
2004-08-01
Project End
2005-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$50,548
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111